课题基金 / 基金详情

Administrative Core - New therapeutic vulnerabilities in breast cancer

Administrative Core - New therapeutic vulnerabilities in breast cancer
行政核心 - 乳腺癌的新治疗漏洞
批准号:
10261469
负责人:
KORNELIA POLYAK
金额:
$11.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-11 至 2025-05-31

项目摘要

项目成果

KORNELIA POLYAK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The goal of the Administrative Core is to provide administrative support to the Program Project Grant, and to actively promote synergy among projects and to facilitate the efficient use of the Cores. The Administrative Core Administrator in the office of the Principal Investigator will be responsible for distributing the Program funds to other participating Project and Core Leaders. In addition, the Administrative Core administrator will be responsible for scheduling and organizing the monthly Program Project meetings and the annual Program Retreats. This includes the scheduling of speakers for the monthly meetings and organizing overnight accommodations, the logistics of meals, and agenda of scientific presentations from PPG and IAB (Internal Advisory Board) member labs, as well as members of the EAB (External Advisory Board) for the annual retreat. The Administrative Core administrator will also be responsible for communication with IEB and EAB members including scheduling meetings and distributing material to be reviewed for these meetings as well as collecting feedback and distributing honoraria to EAB members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic mechanisms of therapeutic resistance
  • 批准号:
    10627962
  • 项目类别:
  • 资助金额:
    $35.88万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
  • 批准号:
    10627981
  • 项目类别:
  • 资助金额:
    $11.34万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
Epigenetic mechanisms of therapeutic resistance
  • 批准号:
    10434103
  • 项目类别:
  • 资助金额:
    $35.88万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
New therapeutic vulnerabilities in breast cancer
  • 批准号:
    10434102
  • 项目类别:
  • 资助金额:
    $171.86万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
国内基金
海外基金
αβ珠蛋白融合基因—Lepore-Boston的结构及表达调控
  • 批准号:
    39370398
  • 项目类别:
    面上项目
  • 资助金额:
    7.0万元
  • 批准年份:
    1993
  • 负责人:
    朱定尔
  • 依托单位: